Related Experiment Video
Updated: May 31, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Successful treatment of pediatric endocarditis and pericarditis due to MRSA with linezolid
Takashi Miyamoto1, Takahiro Tomoyasu, Kagami Miyaji
1The Departments of Cardiothoracic Surgery, Kitasato University School of Medicine, Kanagawa, Japan.
Abstract:
The linezolid treatment for methicillin-resistant Staphylococcus aureus (MRSA) infection was sporadically reported in children. Here we describe a case of a 6 month-old patient underwent mediastinal drainage and artificial conduit removement caused by MRSA infection. After that, linezolid treatment was started and bacteremia was resolved after 14 days of treatment. At discharge, he was no febrile, his blood culture were sterile. We report a case of a patient with MRSA endocarditis treatment with linezolid.
Insights
Linezolid effectively treated a 6-month-old infant with methicillin-resistant Staphylococcus aureus (MRSA) endocarditis and bacteremia. This case highlights linezolid as a viable option for pediatric MRSA infections after surgical intervention.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Therapy
- Cardiovascular Infections
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) infections pose significant challenges in pediatric populations.
- Limited data exists on linezolid's efficacy for invasive MRSA infections in infants.
- Surgical intervention is often necessary for complex MRSA infections, such as those involving prosthetic materials.
Observation:
- A 6-month-old infant presented with a severe MRSA infection requiring mediastinal drainage and artificial conduit removal.
- Following surgical management, the infant was treated with linezolid.
- The patient's clinical status was closely monitored throughout the treatment course.
Findings:
- Linezolid treatment led to the resolution of bacteremia within 14 days.
- The infant achieved a febrile-free state and sterile blood cultures by the time of discharge.
- Successful treatment of MRSA endocarditis was documented.
Implications:
- This case supports the use of linezolid as a critical therapeutic option for pediatric MRSA endocarditis and bacteremia.
- Linezolid can be a valuable tool in managing complex pediatric infections post-surgical intervention.
- Further research into linezolid's role in treating resistant bacterial infections in neonates and infants is warranted.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Endocarditis III: Medical Management
Rocky Mountain Spotted Fever
Endocarditis IV: Nursing Management
Mitral Stenosis III: Medical Management

